Stifel maintains Synopsys stock Buy rating, $620 target

On Thursday, Stifel analysts maintained a Buy rating and a $620.00 price target for Synopsys stock (NASDAQ:SNPS), following the company’s SNUG conference. According to InvestingPro data, analysts are overwhelmingly bullish on the stock, with price targets ranging from $520 to $690, and 10 analysts have recently revised their earnings expectations upward. During the event, Synopsys President and CEO Sassine Ghazi’s keynote addressed the evolving landscape of system-level and silicon-level design, emphasizing the shift towards more complex processes driven by accelerated compute applications. The company’s strong financial position, with impressive gross profit margins of 81.35% and more cash than debt on its balance sheet, positions it well to invest in these technological advances.

Ghazi pointed out the transition from Moore’s Law to what Synopsys calls "AI-driven scaling laws," which necessitates a transformation in design practices to accommodate the increased complexity of silicon and systems. He underlined the company’s focus on integrating agentic AI into future design methodologies, moving beyond the assistance that generative AI currently provides.

The highlight of the presentation was the introduction of AgentEngineer, a new design tool powered by AI agents. This tool is designed to streamline the workload-intensive tasks of computing-driven design, allowing for more efficient and complex design processes.

Stifel’s analysis suggests that Synopsys is well-positioned to benefit from these industry shifts over the long term. The firm’s advancements in EDA (Electronic Design Automation) are expected to meet the growing demand for more intricate design activities, as the necessity for accelerated compute continues to rise. InvestingPro analysis reveals the company’s strong financial health with a "GOOD" overall score, supported by robust cash flows and profitability metrics. For deeper insights into Synopsys’s financial health and growth potential, investors can access the comprehensive Pro Research Report, available exclusively to InvestingPro subscribers.

Synopsys’ dedication to innovation and its strategic focus on AI applications in design processes are key factors reinforcing Stifel’s positive outlook on the company’s stock. With revenue growth of 8.51% in the last twelve months and a strong return on equity of 16%, the company’s financial performance supports its innovation initiatives. The reaffirmed price target of $620.00 reflects the analysts’ confidence in Synopsys’ growth trajectory and its role in the future of design automation.

In other recent news, Synopsys reported its first-quarter results for fiscal year 2025, surpassing earnings expectations with a non-GAAP EPS of $3.03, compared to the consensus estimate of $2.79. Revenue also exceeded the midpoint of the company’s guidance, despite a notable 28% decline in China-based revenue, excluding SIG. Stifel analysts maintained their Buy rating for Synopsys, with a $620 price target, expressing optimism about the company’s potential for growth, particularly through AI-related tools. Additionally, Synopsys’ $35 billion acquisition of Ansys (NASDAQ:ANSS) has cleared a significant regulatory hurdle, receiving approval from the UK Competition and Markets Authority. The acquisition, initially announced in January, is expected to expand Synopsys’ product offerings and is anticipated to finalize in the first half of 2025. Synopsys has also filed key documentation with the SEC, including audited financial statements and pro forma financial data, to illustrate the potential impact of the merger. In collaboration with NVIDIA (NASDAQ:NVDA), Synopsys aims to significantly accelerate chip design processes, with plans to optimize over 15 solutions for the NVIDIA Grace CPU architecture by 2025. These developments highlight Synopsys’ strategic efforts to enhance its capabilities and expand its market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.